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Abstract
Driven by the impact of influenza A viruses on human and animal health, much research is conducted on this pathogen. To
support this research, we designed an all influenza A-embracing reverse transcription-PCR (RT-PCR) for the generation of
DNA from influenza A virus negative strand RNA genome segments for full-length genome deep sequencing on a Genome
Sequencer FLX instrument. For high reliability, the RT-PCRs are designed such that every genome segment is divided into
two amplicons and for the most variable segments redundancy is included. Moreover, to minimize the risk of contamination
of diagnostic real-time PCRs by sequencing amplicons, RT-PCR does not generate amplicons that are amenable to RT-qPCR
detection. With the presented protocol we were able to generate virtually all amplicons (99.3% success rate) from isolates
representing all so far known 16 hemagglutinin and 9 neuraminidase subtypes and from an additional 2009 pandemic
influenza A H1N1 virus. Three isolates were sequenced to analyze the suitability of the DNA for sequencing. Moreover, we
provide a short R script that disambiguates the sequences of the primers used. We show that using unambiguous primer
sequences for read trimming prior to assembly with the genome sequencer assembler software results in higher quality of
the final genome sequences. Using the disambiguated primer sequences, high quality full-length sequences for the three
isolates used for sequencing trials could be established from the raw data in de novo assemblies.
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Introduction
Influenza A virus is one of the major threats in modern health
care. Besides influenza viruses that cause seasonal epidemics,
pandemic viruses such as the 2009 H1N1 swine origin influenza A
virus have a significant impact on human and animal health.
Therefore, intensive research is carried out tackling different
aspects of influenza A virus properties, very often trying to
correlate phenotypes with genotypes.
The segmented negative strand RNA genome of influenza A
virus comprises 8 segments ranging in size approximately from
850 nt to 2350 nt. Novel viruses arise due to antigenic drift and
antigenic shift. Antigenic drift is caused by continuous mutation of
the genomes due to the high error rate of the viral RNA-
dependent RNA-polymerase. Reassortments of genome segments
during infection of a single host with different influenza A viruses
result in antigenic shift (reviewed in [1]). Consequently, a high
variability of the genome composition leading to diverse virus
mixtures may be expected. Therefore, the complete characteriza-
tion of influenza A viruses is only possible by precise determination
of full-length genome sequences by deep sequencing. Also for
diagnostics, there is the need for comprehensive tools in this field.
This demand has been highlighted once more by the sudden and
unexpected emergence and fast spread of the pandemic H1N1
swine origin influenza A virus in 2009.
The existing DNA sequencing capacity that is now available
with the different next generation sequencing technologies [2]
more than suffices to accurately sequence any DNA sample at any
desired sequence depth. On the contrary, adequate protocols for
correspondingly satisfying preparation of DNA in sufficient
amount and quality for sequencing of complete virus genomes
are not at hand.
The most apparent problem in full-length virus genome
sequencing is to target the sequencing process away from host
nucleic acids to viral nucleic acids. Preparing a simple shotgun
sequencing DNA library, the most comprehensive approach, will
most likely result in a huge amount of host specific instead of full-
length viral sequences. The same holds true when working with
libraries prepared from cDNA synthesized from RNA with
random priming [3,4]. So far, different techniques to focus the
sequencing have been described [5,6,7,8]. First of all, the most
obvious is to enrich virions from cell culture or from host tissue or
fluids by centrifugation before extracting the genomic DNA/RNA
[5]. This may be a very time-consuming and laborious procedure
with sometimes uncertain outcome. Secondly, it is possible to
enrich for the portion of nucleic acids that is the aim of the
sequencing effort if these can be caught by probing the complete
DNA/RNA. This procedure was engaged, for example, in the first
official RNA sequencing protocol for the Genome Sequencer FLX
(GS FLX) [7]. Here, the influenza A genome segments were
enriched by hybridization to biotinylated probes directed against
the conserved ends of the genome segments. Subsequently, the
probes were bound to streptavidin beads, the samples washed and
finally the captured RNA was eluted. A similar approach was used
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probing total RNA with labeled host nucleic acid. Another
approach to target the sequencing to viral nucleic acid was
published by Potgieter and colleagues [6]. In this case, a protocol
was designed to enrich for double stranded RNA (dsRNA)
exclusively representing the bluetongue virus or other dsRNA-
virus genomes. Nevertheless, as with the first option, targeting the
sequencing effort to a subpopulation of the RNA extracted from a
sample also is laborious and the risk of failure is high, as the
outcome might not be sufficient in quality or amount to allow for
sequencing.
Consequently, it is straightforward to target the sequencing by
simply targeting the preparation of DNA for sequencing by
specific PCR primers. In the case of highly pathogenic avian
influenza A H5N1, it was possible to target and simultaneously
speed up the sequencing by a sensitive and reliable reverse
transcription-PCR (RT-PCR) [9]. Enrichment of virus nucleic
acids by the different available techniques mentioned above was
not necessary. Here, we describe a method that fulfills the demand
for easy and reliable, but in addition at the same time broad and
comprehensive sequencing of influenza A viruses that goes far
beyond the previously reported specialized H5N1 sequencing
approach.
Materials and Methods
Viruses
The virus strains used in this study (see table 1) were obtained
from the virus collection of the National Reference Laboratory for
Avian Influenza at the Friedrich-Loeffler-Institut, Greifswald, Insel
Riems, Germany.
RNA extraction
Total RNA was isolated from allantoic fluid with Trizol LS
(Invitrogen, Darmstadt, Germany) in combination with RNeasy
Mini spin columns (Qiagen, Hilden, Germany). First, 250 mlo f
allantoic fluid were mixed with 750 ml Trizol LS and processed as
recommended by the manufacturer until phase separation. Instead
of RNA precipitation, the RNA containing aqueous phase was
then mixed with ethanol (final concentration $40% (vol/vol)) and
loaded onto an RNeasy Mini spin column. Subsequently, the
RNeasy Mini protocol was followed until elution of RNA.
Alternatively, total RNA was isolated from allantoic fluid
(140 ml) with a QIAamp viral RNA minikit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions.
PCR, library preparation, sequencing, and sequence
assembly
DNA was generated either in a one-step or in a two-step RT-
PCR. For the one-step RT-PCR protocol, cDNA was generated
from total RNA diluted 10-fold in RNA-safe buffer (50 ng/ml
carrier RNA, 0.05% Tween 20, 0.05% sodium azide in RNase-
free water) [10] by RT-PCR with a SuperScript III one-step RT-
PCR system with Platinum Taq high-fidelity polymerase (Invitro-
gen). For every complete influenza A genome, 16 PCRs were set
up with the primer combinations listed in table 2. Five microliters
of the dilute template and 1 ml of each primer (10 mM; final
concentration in the PCR mixture, 0.4 mM) were mixed and
denatured for 2 min at 95uC. Immediately after denaturation, the
samples were frozen in liquid nitrogen, and subsequently, 18 mlo f
the PCR master mixture (12.5 ml2 6 reaction mixture, 1 ml
Superscript III reverse transcriptase-Platinum Taq high-fidelity
polymerase enzyme mixture, 4.5 ml RNase and DNase-free
distilled water) was added. The RT-PCR was performed in a
model 2720 thermal cycler (Applied Biosystems, Darmstadt,
Germany). The cycling parameters were 30 min at 50uC; 2 min
at 94uC; 40 cycles of 15 s at 94uC, 30 s at 50uC, and 3 min at
68uC; and 1 cycle of a hold for 5 min at 68uC. Alternatively, two-
step RT-PCR was performed with SuperScript VILO cDNA
Synthesis Kit (Invitrogen) and AccuPrime Taq DNA Polymerase
High Fidelity (Invitrogen). For the two-step protocol, 2 separate
reverse transcriptions were performed, one for the 59 parts and
one for the 39 parts of the segments. For this purpose, 5 ml total
RNA were mixed with 4 ml5 6 VILO reaction mix, 2 ml1 0 6
Superscript enzyme mix, and 7 ml RNase and DNase-free distilled
water. To this mix containing random hexamer primers, for the 59
portion of the segments 2 ml of general primer pan-IVA-1F-M13F
(10 mM) or for the 39 portion of the segments 2 ml of RNase and
DNase-free distilled water were added. Reverse transcription was
then performed in a model 2720 thermal cycler (temperature
profile: 10 min at 25uC, 5 min at 42uC, 30 min at 55uC, 5 min at
60uC, 5 min at 85uC, and finally 15 s at 10uC). Immediately after
reverse transcription, PCR was set up. To this end, 2.5 ml of the
cDNA were used as template and combined with 2.5 ml1 0 6
AccuPrime PCR Buffer 1, 0.1 ml AccuPrime Taq High Fidelity,
17.9 ml RNase and DNase-free distilled water, and 2 mlo fa
primer mix containing primers (each 5 mM) for amplification of
the respective portion of the genome segment according to table 2.
The reaction mixes were incubated initially 1 min at 94uC; 40
cycles of 15 s at 94uC, 30 s at 50uC, and 3 min at 68uC; and 1
cycle of a hold for 5 min at 68uC. The PCR products both from
the one-step and the two-step protocol were purified with Ampure
Beads (Beckman Coulter Genomics, Bernried, Germany) accord-
ing to the manufacturer’s instructions. The purified DNA was
quantified with a model 1000 spectrophotometer (NanoDrop
Technologies, Inc., Wilmington, DE) in the double-stranded DNA
mode and was then pooled in equimolar amounts. This DNA pool
(800 ng to 3 mg) was transformed to DNA libraries by using a GS
DNA library preparation kit (Roche, Mannheim, Germany) using
the protocol of Wiley and colleagues [11] with the modifications of
Table 1. Virus isolates used in this study.
Type Virus
H1N1 A/duck/Germersheim/R30/06
H2N2 A/guinea fowl/Germany/DZ3/85
H3N1 A/duck/Germany/R2555/06
H4N6 A/mallard/Fo ¨hr/WV1806-09K/03
H5N2 A/mallard/Fo ¨hr/1313/03
H6N2 A/turkey/Germany/617/07
H7N3 A/duck/Italy/636/03
H8N4 A/turkey/Ontario/6118/68
H9N2 A/duck/Germany/113/95
H10N7 A/chicken/Germany/N/49
H11N6 A//Germany/R2795/06
H12N5 A/duck/Alberta/60/76
H13N8 A/Black-headed gull/Mukran/R2613/06
H14N5 A/mallard/Gurirv/263/82
H15N9 A/shearwater/West Australia/2576/79
H16N3 A/herring gull/Mukran/R2788/06
H1N1 pandemic A/Germany-BY/74/2009
doi:10.1371/journal.pone.0019075.t001
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the DNA libraries, the DNA libraries were subjected to duplicate
emulsion PCRs (emPCR) with the GS emPCR kit I (Roche),
according to the manufacturer’s instructions, with 2 copies per
bead. After bead recovery and enrichment, the beads were
sequenced using a GS LR70 sequencing kit (Roche) and the
appropriate instrument run protocol. The resulting sequencing
reads were sorted according to the genome segments to which they
related and were subsequently assembled into one contig (i.e., a set
of overlapping sequencing reads) per segment with the GS FLX
sequence assembly software newbler (version 2.3; Roche). During
the assembly, the primer sequences were trimmed off the raw data.
In addition, to check whether or not the sequences were complete,
we performed a mapping along appropriate reference sequences
using the GS FLX reference mapper software (version 2.3; Roche).
Results
PCR Design
Primers were designed on the basis of alignments of all influenza
A full-length segment sequences that included the conserved ends
and regardless of the host of the virus isolate available at the time of
primer design. Positioning of the primers for reverse transcription
and amplification was done following three key criteria: (i) None of
the 8 genome segments should be reversely transcribed and
amplified as a single amplicon but for better performance be
divided in a 59-a n da3 9-part. (ii) In order to reduce the risk of PCR
failure caused by non-matching primers due to influenza A virus
evolution, we made use of the conserved regions at both the 59 and
the 39 segment ends as primer binding sites. (iii) To be also
compatible with diagnostic settings, the two amplicons to be
generated for each segment should, if possible, not lead to the
generation of DNA traceable in the real-time PCR assays in use in
diagnostic laboratories for influenza A diagnostics. This prevents
interference with diagnostics by PCR products that might be
released at any step during the sequencing library preparation
process. The RT-PCR design resulting from these considerations is
depicted schematically in figure 1. As can be seen in figure 1 (and
table 2), in some instances, we use redundant inner segment specific
primers. This redundancy is necessary due to the high variability in
the sequences of the respective genome segments.
Generation of sequencing amplicons
The functionality of our PCR protocol was tested with 17 different
influenza A isolates that comprise all so far known 16 hemagglutinin
(HA) and 9 neuraminidase (NA) types. In addition, a 2009 pandemic
H1N1 influenza A virus was included in the panel. Table 3
summarizes the results of the PCRs for all segments from all isolates
that were probed. Altogether, 270 out of 272 PCRs (99.3%) that were
performed were successful, i.e. with only very few exceptions all
amplicons from all isolates could be generated. In no case the PCRs
for both the 59-a n dt h e3 9- fragments for one segment failed.
Therefore, even in the case of a PCR failure we were able to gain
sequence information for the respective genome segment.
Table 2. Primers used for RT-PCR amplification of influenza A virus genomic segments.
Genome segment Primer designation Primer sequence
Approximate product
size (bp)
59 part general forward Pan-IVA-1F_M13F TCCCAGTCACGACGTCGTAGCGAAAGCAGG
1 Pan-IVA-S1-1254R
Pan-IVA-S1-1395R
GCA ATC CTC YTG TGA RAA YAC CAT
ATT GTC RAT RGG TTC AAT TCC CCA
1270
1415
2 Pan-IVA-S2-1253R GAT TGG AGY CCR TCC CAC CA 1370
3 Pan-IVA-S3-1264R
Pan-IVA-S3-1311R
CCT TGT TGA ATT CAC TYT GDA TCC A
YCC TAT YTC ATC AAG YTC TAT CCA
1280
1330
4 Pan-IVA-S4-1451R
Pan-IVA-S4-1565R
ACC AGA AGT TCA GCA TTR TAW GWC C
AAA CAA CCA TTN CCN ATN TCC TTN GCA TT
1385
1495
5 Pan-IVA-S5-1471R CGA TCG GGY TCG BTG CCT T 1490
6 Pan-IVA-S6-1158R
Pan-IVA-S6-1351R
TNT TGC TTW TNG TTC TTC CYA WCC A
CCT CTD ATC AAC TCH ACM YAR AAR CA
1075
1265
7 Pan-IVA-S7-124R TGC AAA AAC ATC TTC AAG TYT CTG 140
8 Pan-IVA-S8-600R
Pan-IVA-S8-635R
CTC GAA CHG TGT TAY CAT TCC A
GNT TCT CCA AGC GAA TCT CTG TA
610
645
39 part general reverse Pan-IVA-1R_M13R GGAAACAGCTATGACCATGAGTAGAAACAAGG
1 Pan-IVA-S1-1051F
Pan-IVA-S1-1102F
GAA GAA GTG CTT ACR GGC AAY CT
GGR TAT GAR GAR TTC ACA ATG GT
1310
1260
2 Pan-IVA-S2-1233F TGA GYC CTG GRA TGA TGA TGG 1130
3 Pan-IVA-S3-957F
Pan-IVA-S3-912F
GAG AAC ATT CTT TGG ATG GAA RGA
TCA TGA GGG RGA GGG RAT ACC
1295
1340
4 Pan-IVA-S4-1157F
Pan-IVA-S4-1198F
CTA TTT GGA GCH ATH GCN GGT TTY AT
GGA ATG RTA GAT GGT TGG TAY GG
730
685
5 Pan-IVA-S5-1448F GGG AGT CTT CGA GCT CTC 155
6 Pan-IVA-S6-866F
Pan-IVA-S6-906F
CAY TWW GAG GAR TGC TCC TGY TA
TCA NAT GTG TNT GCA GRG AYA A
635
595
7 Pan-IVA-S7-76F AGG CCC CCT CAA AGC CGA 970
8 Pan-IVA-S8-526F ATA CTV ATG AGG ATG TCA AAA ATG C 375
doi:10.1371/journal.pone.0019075.t002
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Most importantly, we were interested in the applicability of the
amplicons for sequencing with regard to purity, i.e. absence of
non-specifically amplified host sequences, and with respect to
completeness of the influenza A sequences. Therefore, we
sequenced the DNA fragment pools confected from the PCR
products of three isolates. For this sequencing trials, we chose A/
turkey/Ontario/6118/68 (H8N4), A/shearwater/West Australia/
2576/79 (H15N9), and the 2009 pandemic H1N1 A/Germany-
BY/74/2009 (H1N1).
Primer disambiguation for sequence analysis
In general, in assemblies of data obtained from sequencing PCR
products it is necessary to trim off the primer sequences before
assembly in order not to distort the final sequences. This is even
more important when amplicons have been generated with
primers including ambiguities, i.e. incompletely specified bases
[13], as is the case with the primers used here. Failure to trim off
the primer sequences will result in final sequences which include
these ambiguities and hence deviate from the true sequence.
The powerful 454 assembler newbler used in this study cannot
handle nucleotide sequence ambiguity codes in trim information
[14]. If there is no clearly dominating base at a certain position, the
assembler is not able to determine the consensus base at that
position. This either leads to low quality basecalls, single base
insertions or deletions, or the software splits the sequences at these
ambiguous positions leading to a fragmentation of the final genome
sequences. Therefore, it is necessary to disambiguate the primer
Figure 1. Schematic of the primer localizations. PCR products used for sequencing are designed such that every segment is amplified in two
amplicons. Moreover, no amplicon containing the complete region necessary for detection in a diagnostic real-time RT-PCR is generated. This reduces
the risk of compromising nucleic acid diagnostics by sequencing amplicons. For some segments, redundancy is introduced for more reliability.
doi:10.1371/journal.pone.0019075.g001
Table 3. Overview of the PCR results obtained with all different virus isolates.
59 part 39 part
Subtype\Segment 1 2 34567812345678
H1N1 ++++++++++++++++
H1N1 pandemic ++++++++++++++++
H2N2 ++++++++++++++++
H3N1 ++++++++++++++++
H4N6 ++++++++++++++++
H5N2 ++++++++++++++++
H6N2 ++++++++++++++++
H7N3 ++++++++++++++++
H8N4 ++++++++++++++++
H9N2 +++2 ++++++++++++
H10N7 +++2 ++++++++++++
H11N6 ++++++++++++++++
H12N5 ++++++++++++++++
H13N8 ++++++++++++++++
H14N5 ++++++++++++++++
H15N9 ++++++++++++++++
H16N3 ++++++++++++++++
doi:10.1371/journal.pone.0019075.t003
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program (see supplemental File S1) was written. This program
makes use of the seqinr package [16]. Table 4 summarizes the data
obtained in de novo assemblies with or without primer disambigu-
ation. From the numbers shown there it is evident that
disambiguation of the primers enhances final data quality.
Due to the impact of primer disambiguation, for all further
analyses, disambiguated primer sequences were used.
Analysis of data quality, quantity, and usability
For analyses of the quality and quantity of the obtained raw
sequences, we first performed a mapping of the reads along the
known reference sequences. This allowed us to assess the purity,
completeness, and fidelity. Moreover, the raw data were assembled
without any advance sequence information in order to test the
usability for de novo assembly.
Reference mapping. The purity of the generated DNA was
different for the three isolates. In the worst case, A/shearwater/
West Australia/2576/79 (H15N9), the proportion of non-
specifically amplified and subsequently sequenced host nucleic
acids was 3.7%. In the remaining 2 cases, 3.3% (A/turkey/
Ontario/6118/68 (H8N4)) and 1.0% (A/Germany-BY/74/2009
(H1N1)) of all sequencing reads were host sequences.
With regard to completeness, we were particularly curious
whether the complete sequences for segments 5 and 7 could be
generated. This was interesting because we used very short PCR
products (,300 bp) for the 39 and 59 part of these segments,
respectively. Such short DNA fragments are depleted during
preparation of the sequencing libraries. Nevertheless, mapping of
the sequence reads against the appropriate reference sequences
showed that all segments had been completely sequenced. In all
cases, only the sequences of the binding sites of the general
forward and reverse primers, respectively, were missing from the
final sequences due to primer trimming.
Besides the assessment of DNA purity and sequence complete-
ness, mapping also provided information about the fidelity of the
newly generated sequences. The results of the sequence compar-
isons are compiled in table 5. Except for a few deviations in the
regions of the general primers, i.e. outside the coding regions, we
rarely detected sequence deviations in the sequences of all 3 isolates.
With regard to the deviations in the primer regions it is necessary to
note that these occur due to primer trimming. Primer trimming
leads to a diminished sequence depth in the trimmed regions
causing a diminished sequence quality. With regard to those
deviations which were found in the coding regions, we detected 3
differences between newly established and the reference sequences
for all segments of isolate A/shearwater/West Australia/2576/79
(H15N9). Namely, we found one deviation in the HA gene (a677g),
one base substitution in the NA (a866t), and another difference in
the NP gene (a1459c) which is a primer derived substitution. In the
sequences for isolate A/turkey/Ontario/6118/68 (H8N4), we
detected 1 difference within the open reading frames. This n499g
was located in segment 1 and obviously is not a deviation from the
reference sequence. The figures for the pandemic H1N1 virus were
much the same as for the other 2 isolates. Here, we also found a
single deviation from the reference sequences, namely an a837g
substitution in segment 2. In summary, we conclude that the
sequence fidelity achievable with the established protocol is
excellent. With an overall error rate of only 0.032% (including
those deviations that are located in the general primer regions) the
concordance of the newly determined with the beforehand known
reference sequences from all 3 isolates that were sequenced is very
high. It is important to note that the deviations may be acquired by
the virus during repeated cell or egg culture passages.
De novo assembly. In order to test if the quality of the raw
data and the overlaps of the PCR amplicons are sufficient for a de
novo assembly, we assembled the raw sequence data without
advance sequence information. To this end, we performed an
assembly of the raw sequencing reads using the 454 assembler
software newbler. As published before for sequencing of highly
pathogenic avian influenza A H5N1 viruses [9], complete
assembly into a single contig (a set of overlapping sequencing
reads) per segment was only possible after allocating the
sequencing reads to the segments. The assemblies of the data
resulted in one contig per segment for all 3 isolates. Only the
sequence for the segment 7 of the H8N4 was truncated. Here, the
sequence for nucleotides 1–76 was missing in the de novo assembled
sequence, caused by the depletion of the small fragment
representing this region. Hence, the coding sequence for the
H8N4 genome was 99.59% and those for the two other isolates
were 100% complete. The main characteristics of all de novo
assemblies are summarized in table 6. As for mapping, the fidelity
of the de novo assembled sequences was very high. Here, the total
error rate was 0.030%, again including those mutations that were
detected in the general primer binding regions which resulted in a
relatively low quality due to the trimming during the assembly.
The results of the comparisons of our de novo assembled
unrevised sequences with the available reference sequences (table 7)
predominantly showed the same differences which were detected
by mapping (see table 5). Remarkably, four of the deviations
detected by mapping located in the general primer binding regions
were not detected in the assemblies. This provides an additional
hint that these deviations are artifacts. Moreover, with regard to
the coding regions, we did not detect the a866t substitution in the
H15N9 NA sequence. On the other hand, three single nucleotide
deletions were found in the de novo assembled sequences. In
particular, we found one deletion in segment 7 of the pandemic
H1N1, one deletion in segment 6 of the H8N4 virus, and one
deletion in segment 5 of the assembly for the H15N9 virus’s
sequence. From the detailed assembly characteristics stored by the
Table 4. Summary of the impact of primer disambiguation on sequence quality obtained by de novo assembly.
Ambiguous primers Unambiguous primers
Isolate Number of Contigs Number of bases
Number (%) of
Q392 bases
a Number of Contigs Number of bases
Number (%) of
Q392 bases
a
H1N1 23 13814 81 (0.59) 18 13528 49 (0.36)
H8N4 36 13806 84 (0.61) 26 13507 64 (0.47)
H15N9 67 14626 163 (1.11) 51 14301 130 (0.91)
aQ392-bases are those with a quality score of 39 or less, i.e. with probability #99.987%.
doi:10.1371/journal.pone.0019075.t004
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undercalls, i.e. as artifacts in the assembly. Taken together, despite
the differences that are described here, the overall consistency of
the unrevised sequences with the reference sequences is 99.97%.
Discussion
In several reports the possibility to benefit from shotgun high
throughput sequencing for applications in virus research has been
shown (see for instance [5,6,7,8]). However, none of the presented
protocols is useful for targeted full-length genome deep sequenc-
ing. This is due to limitations in the sample preparation caused by
failure to focus or laborious protocols used to target the sequencing
process to the aim of the work. Our previously reported protocol
for sequencing highly pathogenic influenza A H5N1 [9] is very
sensitive, accurate, and useful for the specialized goal. However, its
spectrum is too narrow to be useful in influenza A virus research in
general or in situations like the 2009 pandemic of the swine origin
influenza A H1N1. Therefore, we set out to improve the method
making use of the benefits of our first protocol but adding usability
and broadening the spectrum of the method to influenza A viruses
regardless of the subtype.
The presented results of the sequencing trials done with 3
isolates clearly show that we reached our goal to broaden the
spectrum without losing the specificity that is necessary to target
the sequencing. With a maximum of only 3.7% of the reads
representing host nucleic acids, we obviously successfully direct
sequencing to the influenza A genome. Nevertheless, the scale of
our approach is very good. This is highlighted by a success rate of
about 99.3% for all PCRs as tested with 17 different isolates that
represent all 16 HA and 9 NA types, respectively, and one 2009
pandemic H1N1 virus. Therefore, we conclude that focusing the
sequencing must not necessarily diminish comprehensiveness.
Unlike the protocol for subtype independent sequencing of
influenza A viruses initially provided by 454 life sciences for use
with the GS FLX [7], we neither need delicate techniques for
enrichment of the target nucleic acid nor for preparation of cDNA
carrying the adapters necessary for GS FLX sequencing.
By introduction of the protocol of Wiley and colleagues [11] and
omission of the gel purification initially included in the sequencing
protocol for highly pathogenic influenza A H5N1 [9], we gain the
possibility to fully automate sample preparation. Only quantifica-
tion of the PCR products and preparation of the DNA pools has to
be done manually. This permits to raise the throughput which is
possible since the introduction of the MID adapters for the GS
FLX. These MID adapters provide a recognizable sequence tag at
the beginning of each read. These tags allow to group the
sequence reads belonging to different DNA libraries. Taken
together, this makes sequencing less laborious and more economic.
Another benefit of the new protocol presented here is the design
of the PCRs in order not to compromise diagnostic qPCR assays
in use in influenza diagnostic laboratories. With the exception of
the two small fragments generated for sequencing the M and NP
segments, none of the sequencing amplicons is detectable in the
respective qPCR assays (data not shown). Therefore, laboratories
can be protected from sequencing amplicons that may interfere
with real-time PCR diagnostics. Skipping the two small fragments
Table 5. Details of the sequence comparison performed by mapping the generated sequencing reads along the previously
reported sequences as a reference.
H1N1 H8N4 H15N9
Segment Reference
a Deviations
b Reference
a Deviations
b Reference
a Deviations
b
1 HM138498.1 none CY005831.1 n499g (X158E) GU052266.1 none
2 HM138499.1 a837g (silent) CY014662.1 none GU052265.1 none
3 HM138497.1 none CY005830.1 g8-
d CY005410.1 a2220-
d, t2230-
d,
4 HM138501.1 a18-
d CY014659.1 a4g
cd, -1736t
d CY006034.1 a677g (Q219R)
5 HM138494.1 a4-
d CY005829.1 none CY005727.1 a1459c
c (T472P)
6 HM138500.1 none CY014660.1 a4g
cd CY005407.1 a866t (Y283F)
7 HM138496.1 none CY005828.1 none GU052261.1 none
8 HM138495.1 none CY014661.1 none GU052263.1 c2t
cd
aGenbank Accessions of the reference sequences used for the mapping.
bNucleotide substitutions, insertions, and deletions compared to the reference sequences indicated in the column reference; the impact on the coded amino acid is
given in parentheses.
cprimer derived deviation.
dmutation outside the coding region.
doi:10.1371/journal.pone.0019075.t005
Table 6. Summary of data characterizing the quantity and quality of the sequences obtained by de novo assembly.
Isolate
Length
(no. of bases)
% Coverage of the coding
sequence
No. (%)
of Q40+ bases
A/Germany-BY/74/2009(H1N1) 13520 100 13458 (99.69)
A/turkey/Ontario/6118/68(H8N4) 13421 99.59 13798 (99.65)
A/shearwater/West Australia/2576/79(H15N9) 13464 100 13223 (99.53)
aQ40+-bases are those with a quality score of 40 or higher, i.e. with probability $99.99%.
doi:10.1371/journal.pone.0019075.t006
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In the case of segment 5, the 59 portion, which is not detectable
with qPCR assays, comprises 95% of the coding region. For
segment 7, the small 59 part adds 17 codons, i.e. about 7% of the
ORF.
Sequencing RNA directly from specimens without enriching for
virus nucleic acids results in high proportions of host sequence
reads. In two different studies in which new viruses were identified
only 0.014% and 0.091% of the reads, respectively, represented
virus sequences [3,4]. This underlines the necessity to direct the
sequencing process. The aforementioned different approaches for
focusing the library preparation and hence the sequencing process
to the virus nucleic acids are less restricted than our approach
[5,6,7,8] but, nevertheless, strong constraints exist: The protocol of
Potgieter and co-workers [6] only works with dsRNA, excluding its
use for influenza sequencing. The authors do not provide
information about the amount of contaminating host reads. With
the random cDNA library preparation protocol currently provided
by Roche/454 Life Sciences paired with the enrichment protocol
of Simons and Hutchison [7], we reached a host sequence
contamination level of 87.5%. Moreover, this protocol relies on
pre-existing knowledge as does our method. Monger and
colleagues [8] report that after de-enrichment of host nucleic
acids by hybridization still 84% of the sequencing reads
represented host sequences. Due to all these inconveniences, we
chose RT-PCR for the targeting. On the one hand, RT-PCR in
general is a very robust and sensitive technique which enables us to
sequence whole genomes from samples with a broad range of virus
content. On the other hand, the focused sequencing results in high
amounts of target sequence data. In turn, this renders sequencing
with any depth that may be desired economically possible. The
huge amount of data enables quasispecies analyses by sequencing
every genome position hundreds or even thousands of times. The
possibility to benefit from deep sequencing data for quasispecies
analysis has already been shown before with African horse sickness
virus and classical swine fever virus [6,12]. With our here
presented protocol, this kind of analyses is made possible for all
subtypes of influenza A viruses.
Altogether, we were able to markedly improve our previously
reported protocol [9]. With the high quality of the final sequence
data that are produced with our technique, we conclude that the
presented method is suitable for routinely sequencing complete
influenza A virus genomes with a high throughput. In addition,
due to the great sequence depth that can be achieved even
quasispecies analysis at the full genome level is made possible.
Supporting Information
File S1 This file contains the R-code that disambiguates
nucleotide sequences and writes a new file containing these
disambiguated sequences. The script relies on the seqinr package
[16].
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